Cécile Tomowiak

14PUBLICATIONS
78CO-AUTHORS
Haematological tumoursHaematologyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 20, 2026
Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

|Nov 05, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia.

Cécile Tomowiak, Stéphanie Poulain, Morgane Nudel

|Jun 27, 2024
Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Jérôme Paillassa, Elsa Maitre, Nadia Belarbi Boudjerra

|May 19, 2023
Hairy cell leukemia with isolated bone lesions.

Laura Cailly, Cécile Gruchet, Elsa Maitre

|Apr 07, 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.

Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier

|Feb 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.

Christian Buske, Meletios A Dimopoulos, Alexander Grunenberg

Pageof 3

Frequent Collaborators

3 joint publications

Xavier Troussard

3 joint publications

Pierre Morel

3 joint publications

Olivier Tournilhac

3 joint publications

Alain Jacques Delmer